Navarro, Merlindo D.
HRN: 06-78-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
CEFTAZIDIME 1GM (VIAL)
10/26/2023
11/08/2023
IVTT
1gram
Q8h
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes